BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31566384)

  • 1. Development of Chemical Entities Endowed with Potent Fast-Killing Properties against
    Matralis AN; Malik A; Penzo M; Moreno I; Almela MJ; Camino I; Crespo B; Saadeddin A; Ghidelli-Disse S; Rueda L; Calderon F; Osborne SA; Drewes G; Böesche M; Fernández-Álvaro E; Martin Hernando JI; Baker DA
    J Med Chem; 2019 Oct; 62(20):9217-9235. PubMed ID: 31566384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.
    Vanaerschot M; Murithi JM; Pasaje CFA; Ghidelli-Disse S; Dwomoh L; Bird M; Spottiswoode N; Mittal N; Arendse LB; Owen ES; Wicht KJ; Siciliano G; Bösche M; Yeo T; Kumar TRS; Mok S; Carpenter EF; Giddins MJ; Sanz O; Ottilie S; Alano P; Chibale K; Llinás M; Uhlemann AC; Delves M; Tobin AB; Doerig C; Winzeler EA; Lee MCS; Niles JC; Fidock DA
    Cell Chem Biol; 2020 Jul; 27(7):806-816.e8. PubMed ID: 32359426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.
    Green JL; Moon RW; Whalley D; Bowyer PW; Wallace C; Rochani A; Nageshan RK; Howell SA; Grainger M; Jones HM; Ansell KH; Chapman TM; Taylor DL; Osborne SA; Baker DA; Tatu U; Holder AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1464-75. PubMed ID: 26711771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisubstituted thiazoles as potent and selective inhibitors of Plasmodium falciparum protein kinase G (PfPKG).
    Tsagris DJ; Birchall K; Bouloc N; Large JM; Merritt A; Smiljanic-Hurley E; Wheldon M; Ansell KH; Kettleborough C; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3168-3173. PubMed ID: 30174152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites.
    Penzo M; de Las Heras-Dueña L; Mata-Cantero L; Diaz-Hernandez B; Vazquez-Muñiz MJ; Ghidelli-Disse S; Drewes G; Fernandez-Alvaro E; Baker DA
    Sci Rep; 2019 May; 9(1):7005. PubMed ID: 31065005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Straimer J; Gnädig NF; Stokes BH; Ehrenberger M; Crane AA; Fidock DA
    mBio; 2017 Apr; 8(2):. PubMed ID: 28400526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crucial piece in the puzzle of the artemisinin resistance mechanism in Plasmodium falciparum.
    Bozdech Z; Ferreira PE; Mok S
    Trends Parasitol; 2015 Aug; 31(8):345-6. PubMed ID: 26169358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors.
    Liu Y; Lu WQ; Cui KQ; Luo W; Wang J; Guo C
    Arch Pharm Res; 2012 Sep; 35(9):1525-31. PubMed ID: 23054708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Antiparasitic Compound Kills Ring-Stage Plasmodium falciparum and Retains Activity Against Artemisinin-Resistant Parasites.
    Clements RL; Streva V; Dumoulin P; Huang W; Owens E; Raj DK; Burleigh B; Llinás M; Winzeler EA; Zhang Q; Dvorin JD
    J Infect Dis; 2020 Mar; 221(6):956-962. PubMed ID: 31616928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
    Heller LE; Goggins E; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief history of artemisinin: Modes of action and mechanisms of resistance.
    Lu F; He XL; Richard C; Cao J
    Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retargeting azithromycin analogues to have dual-modality antimalarial activity.
    Burns AL; Sleebs BE; Siddiqui G; De Paoli AE; Anderson D; Liffner B; Harvey R; Beeson JG; Creek DJ; Goodman CD; McFadden GI; Wilson DW
    BMC Biol; 2020 Sep; 18(1):133. PubMed ID: 32993629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.
    Wang J; Zhang CJ; Chia WN; Loh CC; Li Z; Lee YM; He Y; Yuan LX; Lim TK; Liu M; Liew CX; Lee YQ; Zhang J; Lu N; Lim CT; Hua ZC; Liu B; Shen HM; Tan KS; Lin Q
    Nat Commun; 2015 Dec; 6():10111. PubMed ID: 26694030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small-molecule inhibitor of the DNA recombinase Rad51 from
    Vydyam P; Dutta D; Sutram N; Bhattacharyya S; Bhattacharyya MK
    J Biol Chem; 2019 May; 294(20):8171-8183. PubMed ID: 30936202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.